BMO Family Office
The recently released “America’s Patients First: The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs” looks to make good on the president’s campaign promise to reduce the cost of prescription drugs.
The plan identifies four major challenges and four key strategies to overcome them.
While the blueprint is long on ideas, it is short on specific action points.
Pharmaceutical stock valuations may rebound with more clarity as they have been compressed for years due in part to ongoing political uncertainty.
Download our Current Market News to learn more.
Stay on top of the latest news and insights from BMO Wealth Management